Predicting the Feasibility of Post-TAVR Coronary Access and Redo TAVR: More Unknowns Than Knowns

Gilbert H.L. Tang; Tsuyoshi Kaneko; João L. Cavalcante

doi:10.1016/j.jcin.2020.01.222

Predicting the Feasibility of Post-TAVR Coronary Access and Redo TAVR: More Unknowns Than Knowns

Gilbert H.L. Tang, Tsuyoshi Kaneko, João L. Cavalcante

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	736-738
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	13
Issue number	6
DOIs	https://doi.org/10.1016/j.jcin.2020.01.222
State	Published - Mar 23 2020

Keywords

TAVR
coronary access
redo TAVR

Access to Document

10.1016/j.jcin.2020.01.222

Cite this

@article{3388b26c452c4e3e854aec7a3d9699cc,

title = "Predicting the Feasibility of Post-TAVR Coronary Access and Redo TAVR: More Unknowns Than Knowns",

keywords = "TAVR, coronary access, redo TAVR",

author = "Tang, {Gilbert H.L.} and Tsuyoshi Kaneko and Cavalcante, {Jo{\~a}o L.}",

note = "Funding Information: Dr. Tang is a physician proctor for Edwards Lifesciences; and is a physician proctor and consultant for Medtronic. Dr. Cavalcante has received consulting fees from Boston Scientific and Abbott Vascular; and has received research grant support from Edwards Lifesciences, Medtronic, Boston Scientific, and Abbott Vascular. Dr. Kaneko has reported that he has no relationships relevant to the contents of this paper to disclose.",

year = "2020",

month = mar,

day = "23",

doi = "10.1016/j.jcin.2020.01.222",

language = "English",

volume = "13",

pages = "736--738",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

number = "6",

}

TY - JOUR

T1 - Predicting the Feasibility of Post-TAVR Coronary Access and Redo TAVR

T2 - More Unknowns Than Knowns

AU - Tang, Gilbert H.L.

AU - Kaneko, Tsuyoshi

AU - Cavalcante, João L.

N1 - Funding Information: Dr. Tang is a physician proctor for Edwards Lifesciences; and is a physician proctor and consultant for Medtronic. Dr. Cavalcante has received consulting fees from Boston Scientific and Abbott Vascular; and has received research grant support from Edwards Lifesciences, Medtronic, Boston Scientific, and Abbott Vascular. Dr. Kaneko has reported that he has no relationships relevant to the contents of this paper to disclose.

PY - 2020/3/23

Y1 - 2020/3/23

KW - TAVR

KW - coronary access

KW - redo TAVR

UR - http://www.scopus.com/inward/record.url?scp=85081275564&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2020.01.222

DO - 10.1016/j.jcin.2020.01.222

M3 - Editorial

C2 - 32192694

AN - SCOPUS:85081275564

SN - 1936-8798

VL - 13

SP - 736

EP - 738

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 6

ER -

Predicting the Feasibility of Post-TAVR Coronary Access and Redo TAVR: More Unknowns Than Knowns

Keywords

Access to Document

Other files and links

Cite this